JNJames Newman

James Newman

*This is an algorithmically generated author record based on publicly available information.

James Newman has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A dose-response study of nanosecond electric energy pulses on facial skin

    by James Newman, Lauren Jauregui, William A. Knape, Edward Ebbers, Darrin Uecker, Darius Mehregan, Richard Nuccitelli

    Nanosecond pulsed electric fields, also known as Nano-Pulse Stimulation or NPS, can trigger regulated cell death to clear skin lesions that are cellular in nature. Before treating facial lesions, i...


  • Open Access

    Multicenter Efficacy Trial of a Percutaneous Radiofrequency System for the Reduction of Glabellar Lines

    by James Newman, James Chan, Z Paul Lorenc, Braden C Stridde, David James Russell

    Background: Bipolar percutaneous radiofrequency (RF) is an established method for ablation of distal peripheral branches of the facial nerve to produce weakness of the corrugator muscle. Recent developments to the Serene RF system (Serene Medical, Inc., Pleasanton, CA) allowing for safer and more predictable results highlighted a need for prospective clinical data. Objectives: The authors sought to assess the ability of percutaneous RF to safely improve the appearance of dynamic glabellar lines for a minimum of 3 months and up to 1 year. Methods: This prospective study enrolled 78 patients across 5 centers in the United States. The most distal branches of the medial and lateral facial nerve innervation to the brow depressor/corrugator complex were treated. Follow-up was at 3 days by telephone and in-office at 7 days and 3, 6, 9, and 12 months posttreatment. Patients were evaluated employing the Merz scale for dynamic glabellar lines. Results: At 3 months, 93.6% of patients had a ≥1-point Merz scale improvement in dynamic glabellar lines based on independent, blinded review. Sustained ≥2-point improvement was present in 60% and 20% of patients at 3 and 12 months, respectively. Overall satisfaction remained >60% through 6 months and >50% at 12 months. All device- or procedure-related adverse events were mild (90%) or moderate (10%) and resolved without medical intervention. Conclusions: Bipolar percutaneous RF may be adopted in conjunction with surgery or as an office-based procedure where it can serve as a minimally invasive alternative to, or in concert with, Botulinum Toxin A therapy. Level of Evidence: 4:


  • Radiofrequency (GFX™) Ablation for the Reduction of Glabellar Frowning

    by James Newman

    A new minimally invasive procedure is described for the reduction of glabellar frowning. Glabellar furrow relaxation or GFXTM utilizes bipolar radiofrequency energy targeted at peripheral motor nerve fibers to the depressor muscles of the forehead. This procedure is a useful adjunct in forehead rejuvenation when performed concomitantly with blepharoplasty or forehead lifting in a surgical setting. With proper training the procedure can be performed under local anesthesia in the office setting to produce very natural results. The relevant anatomy and technique is described here in detail because this represents new knowledge in facial plastic surgery. A cohort of patients has been studied for over 12 months demonstrating the efficacy of the relaxation that can be achieved with the procedure. The GFX procedure offers the patients and surgeons an alternative treatment to botulinum toxin A when longer lasting relaxation of the forehead depressor muscles is desired.


  • Open Access

    Review of soft tissue augmentation in the face

    by James Newman

    Review of soft tissue augmentation in the face James NewmanFacial Plastic Surgery, Stanford University Medical Center, Palo Alto, CAFacial Plastic Surgery, Stanford University Medical Center, Palo Alto, CA, USA A primary pillar of facial rejuvenation is the replacement of soft tissue atrophy via a variety of augmentation techniques. The techniques can be classified into three categories, skeletal onlay grafts, subcutaneous volumizers, and dermal fillers. While onlay grafts and subcutaneous volumizers have the most persistent results, the emergence of improved dermal fillers in the past 5 years has become increasingly popular. An accurate diagnosis of the level(s) of soft tissue atrophy in the face needs to be made prior to selection of the category or combination of techniques. In the younger patient, the selection of a dermal filler or combination of fillers can be adequate for treatment. A comparison of the composition and characteristics of the available dermal fillers are discussed in detail to assist the clinician in understanding the actual mechanism of soft tissue augmentation. In the more advanced aging face, a combination of the three categories may be necessary to produce optimal results. Just as dermal fillers have become more differentiated to increase their longevity, the non-injectible long-lasting implants are becoming more developed to mimic accurate viscoelastic properties of the facial soft tissues. All three classes of augmentation techniques can provide patients with very satisfactory results as part of overall facial rejuvenation.Keywords: soft tissue, dermal fillers, facial implants, facial augmentation


  • Brow Elevation Ratio

    by Brian P. Kim, Richard L. Goode, James P. Newman

    Research from JAMA Facial Plastic Surgery — Brow Elevation Ratio — A New Method of Brow Analysis


  • Brow Elevation Ratio

    by Brian P. Kim, Richard L. Goode, James P. Newman

    Objective To introduce a novel quantitative method measuring preoperative and postoperative brow position and apply it to a cohort of patients undergoing endoscopic brow suspension. Design Retrospe...


  • Safety and Efficacy of Midface-lifts With an Absorbable Soft Tissue Suspension Device

    by James Newman

    Objective: To evaluate the safety and efficacy of midface-lifting using an absorbable suspension device (Endotine ST). Design: Prospective cohort of 10 consecutive adult female patients seen in a private practice who underwent isolated midface-lift without accompanying eyelid surgery or volume augmentation procedures in the setting of an accredited ambulatory surgical center. All patients underwent endoscopic-assisted midface-lifts with general anesthesia or intravenous sedation. Subperiosteal dissections of the midface were performed with fixation of the Endotine ST device to temporalis fascia. Objective and subjective criteria were recorded and photodocumented during the postoperative period at 1 week and 1, 3, and 6 months. Patient characteristics of erythema, tenderness, and pain were recorded with a visual analog scale. The patients and surgeon rated changes from the baseline condition and overall satisfaction with the procedure at 1, 3, and 6 months. Results: All 10 patients completed the 6-month postoperative follow-up. Nine of the 10 patients had significant improvements in their aesthetic outcome. The most common objective symptom of malar sensitivity diminished significantly between the 1- and 3-month visits. One patient experienced a temporary paresis of the zygomaticofacial nerve that resolved at 3 months. There were no major complications of infection, extrusion, skin irregularities, or device removals. Conclusions: Midface-lifting with the Endotine ST device provided significant elevation of the malar fat pad with improvement in facial contour. Safety of this surgical technique was comparable to that of midface-lifts in other published studies. Patient acceptance of the midface-lift using the Endotine ST device was favorable. Temporary tenderness over the malar area can be expected during the early postoperative period.